HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro chemotherapy of steroid receptor positive human meningioma low-passage primary cultures with nitrosourea-methionine-steroid conjugates.

Abstract
The antiproliferative activity of two nitrosourea-methionine-steroid conjugates, N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl] (CNC)-L-methionine-testosterone-17-ester and CNC-L-methionine-dihydrotestosterone-17-ester, was investigated in two meningioma low-passage primary cultures that had been derived from human meningiomas and characterized with regard to proliferation pattern and progesterone receptor content. Treatment was given over 4 days. Cytotoxicity (concentrations investigated: 50, 100, and 200 microM) was compared with the effects of the equimolar mixtures of CNC-Met plus steroid. The steroid-linked nitrosoureas were superior to their unlinked components. CNC-Met itself displayed no or marginal activity, whereas the steroid component displayed significant activity.
AuthorsF J Taut, W J Zeller
JournalClinical neuropharmacology (Clin Neuropharmacol) Vol. 19 Issue 6 Pg. 520-5 (Dec 1996) ISSN: 0362-5664 [Print] United States
PMID8937791 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • N-(N'-(2-chloroethyl)--N'-nitrosocarbamoyl)methionine-dihydrotestosterone-17-ester
  • N-(N'-(2-chloroethyl)-N'--nitrosocarbamoyl)methionine-testosterone-17-ester
  • Nitrosourea Compounds
  • Receptors, Steroid
  • Testosterone
Topics
  • Antineoplastic Agents (pharmacology)
  • Drug Screening Assays, Antitumor
  • Female
  • Humans
  • Meningeal Neoplasms (drug therapy, ultrastructure)
  • Meningioma (drug therapy, ultrastructure)
  • Middle Aged
  • Nitrosourea Compounds (pharmacology)
  • Receptors, Steroid (analysis)
  • Testosterone (analogs & derivatives, pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: